One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

GLP-1 Drugs: Demand Surges in a Long-Established Market The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research.